Article Information
vol. 10 no. 440
- Received for publication January 23, 2018
- Accepted for publication April 20, 2018
- .
Author Information
- Adele de Masson1,*,
- John T. O’Malley1,*,
- Christopher P. Elco1,
- Sarah S. Garcia1,
- Sherrie J. Divito1,
- Elizabeth L. Lowry1,
- Marianne Tawa1,
- David C. Fisher2,
- Phillip M. Devlin3,
- Jessica E. Teague1,
- Nicole R. Leboeuf1,
- Ilan R. Kirsch4,
- Harlan Robins4,
- Rachael A. Clark1,†,‡ and
- Thomas S. Kupper1,†,‡
- 1Department of Dermatology, Brigham and Women’s Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
- 2Center for Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
- 3Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, Boston, MA 02115, USA.
- 4Adaptive Biotechnologies, Seattle, WA 98102, USA.
- ↵‡Corresponding author. Email: tkupper{at}bwh.harvard.edu (T.S.K.); rclark{at}bwh.harvard.edu (R.A.C.)